CIK 0001468929 · <br>Emerging growth company
NEXGEL, INC.
Sign in to watch- Ticker
- NXGL
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264042544
- Phone
- 215 702-8550
- Business address
- 2150 CABOT BLVD WEST,, SUITE B, LANGHORNE, PA, 19047
- Former names
- NEXGEL, INC., AquaMed Technologies, Inc.
Securities
- NXGL Common Stock Nasdaq
- NXGLW Warrant Nasdaq
- Open-market buys, last 90 days
- $757,691
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$757,691. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-25 | STEIN NACHUM Director | Purchase | +2,000 | $1.20 | $2K | 484,458 |
| 2022-11-25 | STEIN NACHUM Director | Purchase | +2,000 | $1.20 | $2K | 484,458 |
| 2022-11-23 | STEIN NACHUM Director | Purchase | +100 | $1.20 | $120 | 483,458 |
| 2022-11-23 | STEIN NACHUM Director | Purchase | +100 | $1.20 | $120 | 483,458 |
| 2022-11-21 | STEIN NACHUM Director | Purchase | +2,000 | $1.17 | $2K | 483,358 |
| 2022-11-21 | STEIN NACHUM Director | Purchase | +2,000 | $1.17 | $2K | 483,358 |
| 2022-08-30 | STEFANSKY DAVID Director | Purchase | +5,000 | $1.66 | $8K | 27,591 |
| 2022-08-30 | Spinrad Yaakov Director | Purchase | +1,648 | $1.68 | $3K | 1,648 |
| 2022-08-25 | STEFANSKY DAVID Director | Purchase | +5,000 | $1.73 | $9K | 22,591 |
| 2022-08-16 | STEFANSKY DAVID Director | Purchase | +2,500 | $1.79 | $4K | 17,591 |
| 2022-08-15 | STEFANSKY DAVID Director | Purchase | +2,872 | $1.90 | $5K | 15,091 |
| 2022-06-24 | STEFANSKY DAVID Director | Purchase | +3,128 | $1.60 | $5K | 12,219 |
| 2022-05-31 | Drapczuk Adam E III Chief Financial Officer | Purchase | +5,000 | $1.54 | $8K | 20,000 |
| 2022-05-27 | Drapczuk Adam E III Chief Financial Officer | Purchase | +15,000 | $1.63 | $24K | 15,000 |
| 2022-03-25 | ZELDIS JEROME B Director | Purchase | +5,300 | $1.89 | $10K | 88,028 |
| 2022-03-25 | Levy Adam R. CEO | Purchase | +1,250 | $1.89 | $2K | 295,408 |
| 2022-03-25 | STEIN NACHUM Director | Purchase | +5,000 | $1.90 | $10K | 481,358 |
| 2022-03-25 | glassman steven mark Director | Purchase | +5,500 | $1.87 | $10K | 115,092 |
| 2021-12-27 | ZELDIS JEROME B Director | Purchase | +9,091 | $5.49 | $50K | 82,728 |
| 2021-12-27 | ZELDIS JEROME B Director | Grant or award · Warrant to Purchase Common Stock | +9,091 | $0.01 | $91 | 9,091 |
Page 8 of 9 · 176 trades